ATE52186T1 - Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom. - Google Patents

Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Info

Publication number
ATE52186T1
ATE52186T1 AT86112137T AT86112137T ATE52186T1 AT E52186 T1 ATE52186 T1 AT E52186T1 AT 86112137 T AT86112137 T AT 86112137T AT 86112137 T AT86112137 T AT 86112137T AT E52186 T1 ATE52186 T1 AT E52186T1
Authority
AT
Austria
Prior art keywords
glaucoma
reductase inhibitor
useful
treatment
aldose reductase
Prior art date
Application number
AT86112137T
Other languages
English (en)
Inventor
Billie Murray York Jr
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE52186T1 publication Critical patent/ATE52186T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86112137T 1986-09-02 1986-09-02 Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom. ATE52186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86112137A EP0258476B1 (de) 1986-09-02 1986-09-02 Aldose-Reductase-Hemmer, nützlich bei der Behandlung von Glaukom

Publications (1)

Publication Number Publication Date
ATE52186T1 true ATE52186T1 (de) 1990-05-15

Family

ID=8195385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86112137T ATE52186T1 (de) 1986-09-02 1986-09-02 Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.

Country Status (3)

Country Link
EP (1) EP0258476B1 (de)
AT (1) ATE52186T1 (de)
DE (1) DE3670570D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0384416T3 (da) * 1989-02-22 1994-02-28 Sanwa Kagaku Kenkyusho Co Farmaceutisk sammensætning indeholdende hydantoinderivat
GB8917323D0 (en) * 1989-07-28 1989-09-13 Inverni Della Beffa Spa Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
CN103222974A (zh) * 2007-01-31 2013-07-31 株式会社三和化学研究所 视网膜神经或视神经的保护剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3467166D1 (en) * 1983-09-23 1987-12-10 Pfizer Spiro-succinimides for treatment of diabetes complications
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy

Also Published As

Publication number Publication date
EP0258476B1 (de) 1990-04-25
DE3670570D1 (de) 1990-05-31
EP0258476A1 (de) 1988-03-09

Similar Documents

Publication Publication Date Title
NO862528D0 (no) Metode for aa forhindre ocular hypertensjon, behandling av glaucoma og behandling av ocular hypertensjon.
DE69132439D1 (de) Inhibitoren retroviraler Proteasen
NO162124C (no) Forspent bjelke av trevirke.
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
ATE239094T1 (de) Behandlung von amplifizierter dns mit alkalischer phosphatase
DK283881A (da) Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner
DE68907423D1 (de) Behandlung der akne.
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE3584174D1 (de) Rheumamittel.
DK0436199T3 (da) Cyklopropylderivatlipoxygenaseinhibitorer
DE3851533D1 (de) Behandlung von klimaanlagen.
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
SE7610218L (sv) Pilokarpinsalter
IT1240486B (it) Procedimento di ammollo enzimatico per pelli e pellami.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
ATE52186T1 (de) Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.
DE3777656D1 (de) Mittel zur behandlung von alopezien.
DE68908344D1 (de) Oberflaechenbehandlung von metallen.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
ATE122886T1 (de) Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht.
DE3765583D1 (de) Oberflaechenbehandlungsmittel und -verfahren.
DE68922653D1 (de) Herstellungsverfahren von Metall-Halbleiter Feldeffekttransistoren.
ATE241359T1 (de) Topische und systemische anwendung von buspiron und seinen derivaten zur behandlung von pathologischen zuständen, die mit immunantworten verbunden sind
DE68908413D1 (de) Behandlung von metallbrammen.